|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:FDA
1993
|
|
gptkbp:ATCCode
|
N03AX12
|
|
gptkbp:chemicalFormula
|
C9H17NO2
|
|
gptkbp:contraindication
|
hypersensitivity to gabapentin
|
|
gptkbp:drugClass
|
gptkb:analgesic
gptkb:anticonvulsant
|
|
gptkbp:eliminationHalfLife
|
5-7 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:form
|
gptkb:tablet
capsule
oral solution
|
|
gptkbp:genericName
|
gptkb:gabapentin
|
|
gptkbp:indication
|
gptkb:peripheral_neuropathy
gptkb:restless_legs_syndrome
fibromyalgia
hot flashes
partial seizures
|
|
gptkbp:legalStatus
|
prescription only
Rx-only (US)
POM (UK)
Rx-only (Canada)
S4 (Australia)
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:mechanismOfAction
|
modulates voltage-gated calcium channels
|
|
gptkbp:metabolism
|
not significantly metabolized
|
|
gptkbp:offLabelUse
|
bipolar disorder
insomnia
anxiety disorders
migraine prevention
alcohol withdrawal
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
fatigue
drowsiness
ataxia
peripheral edema
|
|
gptkbp:synonym
|
gptkb:gabapentin
|
|
gptkbp:usedFor
|
gptkb:peripheral_neuropathy
epilepsy
postherpetic neuralgia
|
|
gptkbp:bfsParent
|
gptkb:gabapentin
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Neurontin
|